Lifecore Biomedical(LFCR) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Zhitong FinanceMar 18 03:00 ET
New York Manufacturing Hits Low, Inflation Fears Rise
InvestingMar 17 08:50 ET
Lifecore Biomedical Says Humanetics Selected Company To Provide Range Of CDMO Services To Support Continued Development Of BIO 300 For Prevention Of Acute Radiation Syndrome
BenzingaMar 17 07:03 ET
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome
GlobeNewswireMar 17 07:00 ET
Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference
GlobeNewswireFeb 3 07:00 ET
Lifecore Biomedical's Earnings Call: Growth Amid Challenges
TipRanksJan 28 20:13 ET

Comments

Teddy123

Mar 17 20:53

Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome

$Lifecore Biomedical (LFCR.US)$
Lifecore Secures Major Defense Contract: Inside the $5.1M Radiation Protection Drug Program

Jaguar8

Dec 19, 2024 20:05

NEWS

$Lifecore Biomedical (LFCR.US)$
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
Thursday, 19th December at 7:00 am
Development Services Span Tech Transfer, Process Assessment and Method Validation for Fill and Finish of NRS-033 for Planned Phase 2 Trial
Lifecore to Leverage Differentiated Capabilities and Knowledge in Fill and Finish to Support Nirsum's NIH-Funded NRS-033 Development Program
CHASK...

Jaguar8

Nov 27, 2024 05:08

NEWS

$Lifecore Biomedical (LFCR.US)$
Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO
Lifecore Biomedical has announced an amendment and extension of its asset-based lending revolving credit facility with BMO. The amendment extends the facility term by three years to November 2027, simplifies and reduces interest rates, and provides greater flexibility regarding covenants and reporting requirements. This follows the company's recent $24.3 million private placement financ...

Trytosaveabit

Oct 4, 2024 19:23

News

$Lifecore Biomedical (LFCR.US)$ Press Release: Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
Dow Jones· 1 min ago

1

Jaguar8

Aug 27, 2024 05:24

NEWS ER

$Lifecore Biomedical (LFCR.US)$
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update
Lifecore Biomedical (NASDAQ: LFCR) reported its fiscal year 2024 results, showing strong revenue growth of 24.2% to $128.3 million.
The company's CDMO business grew 27%, while its HA raw material manufacturing increased 18%.
Gross profit rose 49.5% to $41.9 million, with margin expanding to 32.6%.
Key highlights include:
Net income from con...

1

LFCR Lifecore Biomedical

Trade Overview

Capital Trend

News

Comments

Market Insights